Full-Time

Account Manager

Strategic

Confirmed live in the last 24 hours

Schrödinger

Schrödinger

501-1,000 employees

Computational platform for drug discovery research

Enterprise Software
Biotechnology
Healthcare

Compensation Overview

$90k - $150kAnnually

+ 25% Bonus

Junior, Mid

Remote in USA

Willingness to travel to customer sites in the US approximately 25% of the time.

Category
Strategic Account Management
Sales & Account Management
Required Skills
Sales
Requirements
  • Bachelor’s degree in Chemistry, Biology, or a related science is required
  • At least two years sales experience in the drug discovery software or enterprise solution space
  • Willingness to travel to customer sites in the US (approximately 25% of the time)
Responsibilities
  • Create and implement strategic sales plans for all allocated accounts
  • Manage all team engagements with assigned accounts to ensure objectives are met
  • Develop and maintain exceptional account relationships through effective communication, education, reporting, and problem-solving
  • Provide feedback from clients to internal Product Managers and the Support teams
  • Collect and communicate market trends to Schrödinger sales/product management

Schrödinger provides a computational platform that aids in the research efforts of biopharmaceutical companies, academic institutions, and government laboratories around the world. Their platform offers advanced computational tools that help in drug discovery and development across various therapeutic areas. Schrödinger's products work by utilizing sophisticated algorithms and simulations to predict how different compounds will interact, which can significantly speed up the research process. Unlike many competitors, Schrödinger not only licenses its software but also engages in collaborative drug discovery programs, allowing them to work closely with clients on specific projects. The company's goal is to enhance scientific research and innovation by providing powerful tools and resources that support the development of new therapies.

Company Stage

IPO

Total Funding

$362.7M

Headquarters

New York City, New York

Founded

1990

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • Schrödinger received a $10M grant to expand predictive toxicology tools.
  • The discovery of SGR-1505 showcases Schrödinger's platform efficiency in drug discovery.
  • Schrödinger's focus on ESG matters enhances corporate reputation and stakeholder trust.

What critics are saying

  • Increased competition from Recursion and Exscientia merger in AI drug discovery.
  • Avicenna's ML-enhanced platform could outpace Schrödinger's capabilities.

What makes Schrödinger unique

  • Schrödinger's platform supports diverse clients, including biopharmaceutical companies and academic institutions.
  • The company engages in both wholly-owned and collaborative drug discovery programs.
  • Schrödinger's computational tools are used in over 70 countries worldwide.

Help us improve and share your feedback! Did you find this helpful?